A trial of the screening for high risk of preeclampsia population suitable for aspirin by AI-assisted fundus examination,plasma biological markers and maternal risk factors

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037714

Enrollment

Unknown

Registered

2020-08-30

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia

Interventions

group ACOG:screening by ACOG

group new method:screening by new method

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: A. Gestational weeks between 12+0 weeks and 15+6 weeks; B. Age between 18 years old and 45 years old; C. Single pregnancy; D. no major fetal malformation E. Consent to periodic medical examinations and delivery at our hospital.

Exclusion criteria

Exclusion criteria: A. Taking aspirin; B. Contraindications for the use of aspirin.

Design outcomes

Primary

Measure	Time frame
incidence of PE;	—

Secondary

Measure	Time frame
pregnancy outcome;fundus examination;	—

Countries

China

Contacts

Public ContactXiaolin Hua

Shanghai First Maternity And Infant Hospital

huaxiaolin_sh@163.com+86 13764509708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026